ACR Stakeholder Prostate Summit

Jeffrey Weinreb; Peter Choyke; Andrei Iagaru; Joseph Ippolito; Mark Lockhart; Gregory Merrick; Sean Sachdev; Ezequiel Silva; Samir S. Taneja; Clare Tempany; Richard Wahl; Andrew Rosenkrantz

doi:10.1016/j.jacr.2020.03.031

ACR Stakeholder Prostate Summit

Jeffrey Weinreb^*, Peter Choyke, Andrei Iagaru, Joseph Ippolito, Mark Lockhart, Gregory Merrick, Sean Sachdev, Ezequiel Silva, Samir S. Taneja, Clare Tempany, Richard Wahl, Andrew Rosenkrantz

^*Corresponding author for this work

Radiation Oncology

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1068-1070
Number of pages	3
Journal	Journal of the American College of Radiology
Volume	17
Issue number	8
DOIs	https://doi.org/10.1016/j.jacr.2020.03.031
State	Published - Aug 2020

Funding

Peter Choyke, MD has a patent for MRI US fusion biopsy method with royalties paid to In Vivo, and a patent computer aided design (CAD) for artificial intelligence system to diagnose prostate cancer on MRI with royalties paid to In Vivo Scan Med. He has a clinical trials agreement (nonfinancial) with Progenics (producer of F18 DCFPyl, a prostate-specific membrane antigen imaging agent). Andrei Iagaru, MD, has received grants from GE Healthcare , Advanced Accelerator Applications, and Progenics Pharmaceuticals. Samir S. Taneja, MD, reports personal fees from Trod Medical, personal fees and other from Sophiris, personal fees from Insightec, personal fees from Francis Medical, outside the submitted work. Clare Tempany, MD has grants from National Institutes of Health /National Institute of Biomedical Imaging and Bioengineering ( NIBIB) EB 015898 and has received personal fees from Profound Medical. Richard Wahl, MD, is a shareholder in Progenics. Andrew Rosenkrantz, MD has received personal fees from Thieme Medical Publishers. The other authors state that they have no conflict of interest related to the material discussed in this article.

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.jacr.2020.03.031

Cite this

@article{cbda5afade03439d8270218863db7669,

title = "ACR Stakeholder Prostate Summit",

author = "Jeffrey Weinreb and Peter Choyke and Andrei Iagaru and Joseph Ippolito and Mark Lockhart and Gregory Merrick and Sean Sachdev and Ezequiel Silva and Taneja, \{Samir S.\} and Clare Tempany and Richard Wahl and Andrew Rosenkrantz",

note = "Funding Information: Peter Choyke, MD has a patent for MRI US fusion biopsy method with royalties paid to In Vivo, and a patent computer aided design (CAD) for artificial intelligence system to diagnose prostate cancer on MRI with royalties paid to In Vivo Scan Med. He has a clinical trials agreement (nonfinancial) with Progenics (producer of F18 DCFPyl, a prostate-specific membrane antigen imaging agent). Andrei Iagaru, MD, has received grants from GE Healthcare , Advanced Accelerator Applications, and Progenics Pharmaceuticals. Samir S. Taneja, MD, reports personal fees from Trod Medical, personal fees and other from Sophiris, personal fees from Insightec, personal fees from Francis Medical, outside the submitted work. Clare Tempany, MD has grants from National Institutes of Health /National Institute of Biomedical Imaging and Bioengineering ( NIBIB) EB 015898 and has received personal fees from Profound Medical. Richard Wahl, MD, is a shareholder in Progenics. Andrew Rosenkrantz, MD has received personal fees from Thieme Medical Publishers. The other authors state that they have no conflict of interest related to the material discussed in this article. ",

year = "2020",

month = aug,

doi = "10.1016/j.jacr.2020.03.031",

language = "English (US)",

volume = "17",

pages = "1068--1070",

journal = "Journal of the American College of Radiology",

issn = "1546-1440",

publisher = "Elsevier BV",

number = "8",

}

TY - JOUR

T1 - ACR Stakeholder Prostate Summit

AU - Weinreb, Jeffrey

AU - Choyke, Peter

AU - Iagaru, Andrei

AU - Ippolito, Joseph

AU - Lockhart, Mark

AU - Merrick, Gregory

AU - Sachdev, Sean

AU - Silva, Ezequiel

AU - Taneja, Samir S.

AU - Tempany, Clare

AU - Wahl, Richard

AU - Rosenkrantz, Andrew

N1 - Funding Information: Peter Choyke, MD has a patent for MRI US fusion biopsy method with royalties paid to In Vivo, and a patent computer aided design (CAD) for artificial intelligence system to diagnose prostate cancer on MRI with royalties paid to In Vivo Scan Med. He has a clinical trials agreement (nonfinancial) with Progenics (producer of F18 DCFPyl, a prostate-specific membrane antigen imaging agent). Andrei Iagaru, MD, has received grants from GE Healthcare , Advanced Accelerator Applications, and Progenics Pharmaceuticals. Samir S. Taneja, MD, reports personal fees from Trod Medical, personal fees and other from Sophiris, personal fees from Insightec, personal fees from Francis Medical, outside the submitted work. Clare Tempany, MD has grants from National Institutes of Health /National Institute of Biomedical Imaging and Bioengineering ( NIBIB) EB 015898 and has received personal fees from Profound Medical. Richard Wahl, MD, is a shareholder in Progenics. Andrew Rosenkrantz, MD has received personal fees from Thieme Medical Publishers. The other authors state that they have no conflict of interest related to the material discussed in this article.

PY - 2020/8

Y1 - 2020/8

UR - http://www.scopus.com/inward/record.url?scp=85088217062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088217062&partnerID=8YFLogxK

U2 - 10.1016/j.jacr.2020.03.031

DO - 10.1016/j.jacr.2020.03.031

M3 - Comment/debate

C2 - 32360452

AN - SCOPUS:85088217062

SN - 1546-1440

VL - 17

SP - 1068

EP - 1070

JO - Journal of the American College of Radiology

JF - Journal of the American College of Radiology

IS - 8

ER -

ACR Stakeholder Prostate Summit

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this